These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1642 related items for PubMed ID: 23647578

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Degree of decrease in central retinal thickness predicts visual acuity response to intravitreal ranibizumab in diabetic macular edema.
    Santos AR, Gomes SC, Figueira J, Nunes S, Lobo CL, Cunha-Vaz JG.
    Ophthalmologica; 2014; 231(1):16-22. PubMed ID: 24280908
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [Abstract] [Full Text] [Related]

  • 7. Refractive changes after pharmacologic resolution of diabetic macular edema.
    Deák GG, Lammer J, Prager S, Mylonas G, Bolz M, Schmidt-Erfurth U, Diabetic Retinopathy Research Group Vienna.
    Ophthalmology; 2014 May; 121(5):1054-8. PubMed ID: 24439462
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HYPERREFLECTIVE RETINAL SPOTS AND VISUAL FUNCTION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN CENTER-INVOLVING DIABETIC MACULAR EDEMA.
    Vujosevic S, Berton M, Bini S, Casciano M, Cavarzeran F, Midena E.
    Retina; 2016 Jul; 36(7):1298-308. PubMed ID: 26689274
    [Abstract] [Full Text] [Related]

  • 14. Short-term fluctuation of diabetic macular edema after intravitreal ranibizumab injection.
    Querques G, Bux AV, Martinelli D, Iaculli C, Del Curatolo MV, Delle Noci N.
    Retina; 2009 Oct; 29(9):1274-81. PubMed ID: 19696699
    [Abstract] [Full Text] [Related]

  • 15. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
    Kim M, Lee P, Kim Y, Yu SY, Kwak HW.
    Ophthalmologica; 2011 Oct; 226(3):138-44. PubMed ID: 21822008
    [Abstract] [Full Text] [Related]

  • 16. Correlation of fundus autofluorescence with spectral-domain optical coherence tomography and vision in diabetic macular edema.
    Chung H, Park B, Shin HJ, Kim HC.
    Ophthalmology; 2012 May; 119(5):1056-65. PubMed ID: 22342014
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diabetic macular oedema quantified with spectral-domain optical coherence tomography--evaluation of boundary line artefacts and the effect on retinal thickness.
    Hodzic-Hadzibegovic D, Sander BA, Lund-Andersen H.
    Acta Ophthalmol; 2015 Feb; 93(1):74-82. PubMed ID: 25042850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 83.